Status:
COMPLETED
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Lead Sponsor:
Instituto Bioclon S.A. de C.V.
Collaborating Sponsors:
University of Arizona
Conditions:
Scorpion Sting Envenomation
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailab...
Detailed Description
The purpose of this Open Label, Multi-Center Treatment Protocol, phase III trial is to examine the safety and efficacy of Anascorp, for treatment of patients envenomed by scorpion sting. The treatmen...
Eligibility Criteria
Inclusion
- Males and females of any age presenting for emergency treatment with clinically important systemic signs of scorpion sting envenomation
- Signed written Informed Consent by patient or legal guardian
Exclusion
- Allergy to horse serum
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
1426 Patients enrolled
Trial Details
Trial ID
NCT00624078
Start Date
May 1 2005
End Date
September 1 2010
Last Update
February 23 2011
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Casa Grande Regional Medical Center
Casa Grande, Arizona, United States, 85222
2
Chandler Regional
Chandler, Arizona, United States, 85224
3
Southeast Arizona Medical Center
Douglas, Arizona, United States, 85260
4
Mercy Gilbert Medical Center
Gilbert, Arizona, United States, 85297